Baker Brian Lee
Insider CIK 1772399 · TPTX VP of Finance and Admin.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-03-23 | 2021-03-24 | 1,298 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-03-23 | 2021-03-24 | 4,545 | — | $0 | 6,494 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-03-23 | 2021-03-24 | 11,904 | — | $0 | 2,165 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-03-23 | 2021-03-24 | 10,688 | — | $0 | 19,668 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-03-23 | 2021-03-24 | 4,545 | $5.12 | $23.3K | 21,863 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-03-23 | 2021-03-24 | 1,298 | $3.20 | $4.2K | 17,318 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-03-23 | 2021-03-24 | 10,688 | $7.43 | $79.4K | 32,551 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 100 | $104.17 | $10.4K | 4,116 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-03-23 | 2021-03-24 | 11,904 | $2.19 | $26.1K | 16,020 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 1,996 | $100.07 | $199.7K | 21,177 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 4,919 | $97.89 | $481.5K | 27,632 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 4,459 | $98.76 | $440.4K | 23,173 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 8,061 | $102.23 | $824.1K | 8,106 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 3,890 | $102.84 | $400.0K | 4,216 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-23 | 2021-03-24 | 5,010 | $100.98 | $505.9K | 16,167 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2021-03-22 | 2021-03-24 | 1,625 | — | $0 | 4,116 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-02-08 | 2021-02-10 | 6,675 | — | $0 | 6,675 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2021-02-08 | 2021-02-10 | 1,483 | — | $0 | 2,491 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-07 | 2021-01-08 | 10,689 | — | $0 | 30,356 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-07 | 2021-01-08 | 4,545 | — | $0 | 11,039 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-07 | 2021-01-08 | 11,905 | — | $0 | 14,069 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-07 | 2021-01-08 | 1,299 | — | $0 | 1,298 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-07 | 2021-01-08 | 4,545 | $5.12 | $23.3K | 21,557 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-07 | 2021-01-08 | 900 | $120.16 | $108.1K | 28,546 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-07 | 2021-01-08 | 2,800 | $122.65 | $343.4K | 29,446 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-07 | 2021-01-08 | 10,689 | $7.43 | $79.4K | 32,246 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-07 | 2021-01-08 | 5,200 | $121.57 | $632.2K | 23,346 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-07 | 2021-01-08 | 1,299 | $3.20 | $4.2K | 17,012 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-07 | 2021-01-08 | 11,905 | $2.19 | $26.1K | 15,713 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-07 | 2021-01-08 | 513 | $123.02 | $63.1K | 1,008 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-07 | 2021-01-08 | 21,825 | $122.44 | $2.67M | 1,521 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-01-06 | 2020-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2019-12-10 | 2020-01-08 | 216 | $31.13 | $6.7K | 3,016 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2019-04-22 | 2019-04-24 | 2,800 | $18.00 | $50.4K | 2,800 | SEC↗ |